Comparison of Adalimumab Monotherapy and a Combination With Azathioprine for Patients With Crohn's Disease: A Prospective, Multicenter, Open-Labeled Clinical Trial (DIAMOND Study)

被引:1
|
作者
Matsumoto, Takayuki
Motoya, Satoshi
Watanabe, Kenji
Hisamatsu, Tadakazu
Nakase, Hiroshi
Yoshimura, Naoki
Ishida, Tetsuya
Kato, Shingo
Nakagawa, Tomoo
Esaki, Motohiro
Nagahori, Masakazu
Matsui, Toshiyuki
Naito, Yuji
Kanai, Takanori
Suzuki, Yasuo
Nojima, Masanori
Watanabe, Mamoru
Hibi, Toshifumi
机构
关键词
D O I
10.1016/S0016-5085(16)30697-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
854
引用
收藏
页码:S182 / S182
页数:1
相关论文
共 50 条
  • [41] Extracorporeal Photopheresis (ECP) in Patients with Steroid-dependent Crohn's Disease: An Open-label, Multicenter, Prospective Trial
    Reinisch, Walter
    Knobler, Robert
    Rutgeerts, Paul J.
    Ochsenkuehn, Thomas
    Anderson, Frank
    von Tirpitz, Christian
    Kaatz, Martin
    van der Woude, C. Janneke
    Parenti, Dennis
    Mannon, Peter J.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (02) : 293 - 300
  • [42] A multicenter, randomized, open-labeled, clinical study to evaluate the effect on cognitive and behavioral function of topiramate compared with carbamazepine as monotherapy in children with benign rolandic epilepsy
    Kang, Hoon-Chul
    Eun, Baik-Lin
    Lee, Chang Wu
    Moon, Han Ku
    Kim, Joon-Sik
    Kim, Dong Wook
    Lee, Joon Soo
    Chae, Kyu Young
    Cha, Byung Ho
    Suh, Eun Sook
    Park, Jung Chae
    Lim, Kyunghwa
    Ha, Eun Hye
    Kim, Heung Dong
    EPILEPSIA, 2006, 47 : 138 - 138
  • [43] Adsorptive granulocyte and monocyte apheresis for refractory Crohn's disease: an open multicenter prospective study
    Fukuda, Y
    Matsui, T
    Suzuki, Y
    Kanke, K
    Matsumoto, T
    Takazoe, M
    Matsumoto, T
    Motoya, S
    Honma, T
    Sawada, K
    Yao, T
    Shimoyama, T
    Hibi, T
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (12) : 1158 - 1164
  • [44] Adsorptive granulocyte and monocyte apheresis for refractory Crohn’s disease: an open multicenter prospective study
    Yoshihiro Fukuda
    Toshiyuki Matsui
    Yasuo Suzuki
    Kazunari Kanke
    Takayuki Matsumoto
    Masakazu Takazoe
    Takayuki Matsumoto
    Satoshi Motoya
    Terasu Honma
    Koji Sawada
    Tsuneyoshi Yao
    Takashi Shimoyama
    Toshifumi Hibi
    Journal of Gastroenterology, 2004, 39 : 1158 - 1164
  • [45] Is It Useful to Monitor Thiopurine Metabolites in Pediatric Patients with Crohn’s Disease on Combination Therapy? A Multicenter Prospective Observational Study
    Kristyna Pospisilova
    Jitka Siroka
    Eva Karaskova
    Ondrej Hradsky
    Tereza Lerchova
    Kristyna Zarubova
    Ivana Copova
    Lucie Gonsorcikova
    Maria Velganova-Veghova
    Irena Francova
    Lubor Urbanek
    Milos Geryk
    Vladimir Mihal
    Jiri Bronsky
    Pediatric Drugs, 2021, 23 : 183 - 194
  • [46] Is It Useful to Monitor Thiopurine Metabolites in Pediatric Patients with Crohn's Disease on Combination Therapy? A Multicenter Prospective Observational Study
    Pospisilova, Kristyna
    Siroka, Jitka
    Karaskova, Eva
    Hradsky, Ondrej
    Lerchova, Tereza
    Zarubova, Kristyna
    Copova, Ivana
    Gonsorcikova, Lucie
    Velganova-Veghova, Maria
    Francova, Irena
    Urbanek, Lubor
    Geryk, Milos
    Mihal, Vladimir
    Bronsky, Jiri
    PEDIATRIC DRUGS, 2021, 23 (02) : 183 - 194
  • [47] Remission and clinical response to open label adalimumab over one year in patients with Crohn's disease
    Hanauer, SB
    Lukas, M
    Macintosh, DG
    Pollack, PF
    Kent, J
    GUT, 2006, 55 : A15 - A15
  • [48] Association between pharmacokinetics of adalimumab and disease outcome in Japanese patients with biologics naive Crohn's disease: a subanalysis of DIAMOND trial
    Motoya, S.
    Nakase, H.
    Matsumoto, T.
    Watanabe, K.
    Hisamatsu, T.
    Yoshimura, N.
    Ishida, T.
    Kato, S.
    Nakagawa, T.
    Nagahori, M.
    Esaki, M.
    Matsui, T.
    Naito, Y.
    Kanai, T.
    Suzuki, Y.
    Nojima, M.
    Watanabe, M.
    Hibi, T.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S345 - S346
  • [49] Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn's disease: an open-label, pilot study
    Tursi, A.
    Elisei, W.
    Picchio, M.
    Zampaletta, C.
    Pelecca, G.
    Faggiani, R.
    Brandimarte, G.
    TECHNIQUES IN COLOPROCTOLOGY, 2014, 18 (11) : 1041 - 1046
  • [50] Comparison of the effectiveness of infliximab and adalimumab in preventing postoperative recurrence in patients with Crohn’s disease: an open-label, pilot study
    A. Tursi
    W. Elisei
    M. Picchio
    C. Zampaletta
    G. Pelecca
    R. Faggiani
    G. Brandimarte
    Techniques in Coloproctology, 2014, 18 : 1041 - 1046